Neurodegenerative diseases: risk and protective factors, longitudinal cohort approaches and advanced experimental models

Basic Information

The balance of awards between the three topics will be decided by the Peer Review Panel and will depend on the quality of the applications. JPco-fuND will support transnational consortia with a minimum of three independent partners from at least 3 of the 20 countries participating in the call. Applicants are advised that their respective funding organisation may not necessarily participate in all three areas of the call and therefore they will need to check on national eligibility criteria well before the submission deadline. A table showing national sponsorship is available in the Call Text. If there are any uncertainties, applicants should consult their national representative in order to verify their funding organisation's position in relation to eligibility to the three research areas. A list of national contact points is provided in the Call Text. Detailed information is provided in the Call Text available on the JPND website.

Network JPco-fuND
Aim of the joint call The aim of the JPco-fuND call is to support a limited number of ambitious, innovative, multi-national and multi-disciplinary collaborative research projects that will add value to the following three research areas. Topic 1: Genetic, epigenetic and environmental risk and protective factors of neurodegenerative diseases Topic 2: Longitudinal cohort approaches in neurodegenerative diseases Topic 3: Advanced animal or cell experimental models of neurodegenerative diseases Proposals may cover more than one of these topics, as long as the relevant work is carried out in a country that will financially support the topic.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Launch date 08/01/2015
Deadline Pre-Proposal 10/03/2015 Submitted proposal: 175
Deadline Full-Proposal 30/06/2015 Submitted proposal: 55
Evaluation End Date 31/10/2015 Successful proposal: 21 Proposals funded: 21
Is call co-funded? Yes
Call follow up funding
  • There are mechanisms in place to monitor technical progress
Call reasons n/a
Research fields
  • Health
Type of research
  • Basic research
  • Applied Research
  • Pre-competitive research
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
  • Large Corporations
Participating networks

Organisations Participating

Country Organisation
Austria Federal Ministry of Science, Research and Economy (BMWFW)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Canada Canadian Institutes of Health Research (CIHR)
Denmark Innovation Fund Denmark (Innofond)
Finland Academy of Finland (AKA)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Israel Medical Research Administration Chief Scientist Office Israeli Ministriy of Health (CSO-MOH)
Italy Ministry of Education, University and Research (MIUR)
Italy Ministry of Health (MOH/MDS)
Luxembourg National Fund for Research (FNR)
Netherlands The Netherlands Organisation for Health Research and Development (ZonMw)
Norway Research Council of Norway (RCN)
Poland National Centre for Research and Development (NCBiR)
Portugal Foundation for Science and Technology (FCT)
Romania Ministry of Education and Research (MEdR)
Slovakia Ministry of Education, Science, Research and Sport of the Slovak Republic (MINEDU)
Spain Institute of Health Carlos III (ISCIII)
Sweden Swedish Research Council (VR/SRC)
Switzerland Swiss National Science Foundation (SNSF/SNF)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)
United Kingdom Medical Research Council (MRC)

Funded Projects

Acronym Title Start End No. partners
3DMinBrain High-Throughput, High-Content Screening of human neuroectode... 01/10/2015 30/09/2019 4
3DPD Advanced modelling of Parkinson’s disease with three-dimensi... 01/04/2016 31/03/2019 5
ADAGE Alzheimer's Disease pathology within the ageing physiology. 01/08/2016 31/07/2019 4
BRIDGET BRain Imaging, cognition, Dementia and next generation GEeno... 01/10/2015 30/06/2019 8
CircProt Synaptic CIRCuit PROTection in AD and HD: BDNF/TrkB and Arc ... 01/04/2016 31/03/2019 8
CureALS Stress granules and proteostasis in motor neurons: towards a... 01/07/2016 30/06/2019 7
DACAPO-AD Deciphering Interactions of Acquired Risk Factors and ApoE-m... 01/09/2016 31/08/2019 5
EADB European DNA bank to decipher the Alzheimer disease missing ... 01/10/2015 30/09/2019 9
EPI-AD Targeting epigenetic dysregulation in the brainstem in Alzhe... 01/07/2016 01/07/2019 5
ESMI European Spinocerebellar Ataxia Type 3/Machado-Joseph Diseas... 01/05/2016 30/04/2019 6
GBA-PARK GBA1 mutations in Parkinson’s disease: clinical and biochemi... 24/02/2016 23/02/2019 5
INSTALZ Genomic Instability in Alzheimer’s Disease and Related Disor... 01/10/2015 30/09/2019 6
MADGIC Generation of Improved cellular and animal Models for identi... 01/01/2016 31/12/2018 8
ModelPolyQ Advanced models of polyglutamine disorders (HD, SCA2, SCA3, ... 01/04/2016 31/03/2019 6
NAB3 Development of a Novel Multicellular In Vitro Model of Alzhe... 01/06/2016 31/05/2019 4
PROP-AD Propagation behaviour of peripheral amyloid-beta towards bra... 01/01/2017 31/12/2019 5
REfrAME Pathway complexities of protein misfolding in neurodegenerat... 01/09/2016 31/08/2019 7
SNOWBALL Cerebral amyloid angiopathy and vascular dementia 01/04/2016 31/03/2019 5
STAD Synapse-to-nucleus communication in Alzheimer's disease 01/06/2016 31/05/2019 3
SYNACTION Unravelling the pathophysiological role of alpha-synuclein a... 01/03/2016 28/02/2019 4
aSynProtec Alpha-synuclein pathology propagation in Parkinson’s disease... 01/12/2015 30/11/2018 8